Peeyush Dalmia, Senior Partner, McKinsey & Company, says,...
Category:
Risk Management
Latest
India’s toxic smog cuts off visibility in several areas
The minimum temperature in Delhi fell to 16.1 degrees Celsius...
World already on cusp of 1.5 degree celsius temp rise, finds new research
Every extra increment of heat risks worsening climate impacts like...
Coronavirus vaccine hope dampens prospects for corporate stay-at-home darlings
“Investors are now focused on how the ‘new normal’ looks … and how sustainable are the tailwinds for such companies as the direct impact of the pandemic on consumer behavior starts to diminish,” MKM Partners analyst Rohit Kulkarni, said
Brazil suspends Sinovac COVID-19 vaccine trial due to severe adverse event
The setback to Sinovac’s efforts contrasts with good news from Pfizer Inc PFE.N which said its experimental COVID-19 vaccine is more than 90% effective based on initial trial results.
Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon
The main issue is that the vaccine, which is based on a novel technology that uses synthetic mRNA to activate the immune system against the virus, needs to be kept at minus 70 degrees Celsius (-94 F) or below.
“The cold chain is going to be one of the most challenging aspects of delivery of this vaccination,” said Amesh Adalja, senior scholar at Johns Hopkins Center for Health Security.
Europe charges Amazon with using its dominance and data to squeeze rivals
The regulator looked into how the company collects data on competitors that sell on its platform, offering everything from electronics and toys to food and kitchenware. It says that Amazon uses that sensitive information, which shows what is proving popular or not, to better target its own products.
Aon’s new quality of Intellectual Property Solution helps companies realize full value of their IP portfolio
“Our Quality of Intellectual Property solution and resulting report helps companies articulate and realize the full value of their IP portfolio for M&A or financing transactions,” said Lewis Lee, CEO of IP Solutions at Aon.
“With QoIP, a deal team can catalogue IP with greater precision, describe its connection to the enterprise’s revenue streams and strategy, and benchmark it against competing IP portfolios. We believe this will help sellers better position their company to the marketplace,.” he said.
SEBI proposes extending risk management committee requirement to top 1,000 listed firms
The committee should be responsible for taking measures for risk mitigation, business contingency plan as well as monitoring and overseeing implementation of the risk management policy, as per the watchdog. It should also be responsible for keeping the board informed about the nature and content of its discussions, recommendations and actions to be taken.
Britain hardens climate disclosures for listed companies
“We will also consult in the first half of 2021 on extending the scope of these rules and also on introducing Taskforce on Climate-related Financial Disclosures obligations for asset managers, life insurers and pension providers,” Rathi told an online conference hosted by the City of London.
Crypto crime slows in 2020, but ‘DeFi’ hacks rise: CipherTrace report
Crypto crime hit $4.5 billion globally in 2019.
So far this year, losses from thefts and hacks, excluding misappropriation and fraud, grew to $468 million as of end-October, up 30% from $361 million for the whole of last year, the CipherTrace report said. About 20% of those hacks, or roughly $98 million, came from “decentralized finance” or DeFi, which are transactions on platforms that facilitate lending outside of banks.
Global Markets: Risk assets cheer Biden win, dollar nurses losses
“The best opportunities now lie within segments of emerging markets, in particular China and North Asia. I believe earnings momentum and valuation put China in a very attractive risk/reward position.”
Chinese shares started higher with the blue-chip CSI300 index .CSI300 up 2.2% on hopes of better Sino-U.S. trade relations under Biden.
Investors bet vaccine sparks revival in beaten down stocks
As the market hype around the U.S. election ebbs, investors are now preparing for good vaccine news, which they believe is a matter of when, not if.
“It’s going to be absolutely massive,” said Stuart Oakley, head of cash currency trading at Nomura in London. “If we get a vaccine, we’re going to see all that pent up demand coming out.”
Of the roughly 45 vaccines undergoing human trials, those from Pfizer and Moderna are seen as possibly winning regulatory approval this year, with AstraZeneca not far behind.
Investors are looking beyond an expected “excitement rally” and at longer-term beneficiaries and short-selling opportunities.